about
Metabolic disturbance in PCOS: clinical and molecular effects on skeletal muscle tissueDevelopment of a specific anaerobic field test for aerobic gymnasticsEffect of short-term high-dose creatine supplementation on measured GFR in a young man with a single kidneyCardiac autonomic impairment and chronotropic incompetence in fibromyalgia.Creatine supplementation spares muscle glycogen during high intensity intermittent exercise in rats.Responsiveness to exercise training in juvenile dermatomyositis: a twin case studyCreatine monohydrate supplementation on lower-limb muscle power in Brazilian elite soccer players.Low and moderate, rather than high intensity strength exercise induces benefit regarding plasma lipid profile.Similar health benefits of endurance and high-intensity interval training in obese children.Safety and possible effects of low-intensity resistance training associated with partial blood flow restriction in polymyositis and dermatomyositis.Bone plasticity in response to exercise is sex-dependent in rats.Low dynamic muscle strength and its associations with fatigue, functional performance, and quality of life in premenopausal patients with systemic lupus erythematosus and low disease activity: a case-control study.Creatine supplementation associated or not with strength training upon emotional and cognitive measures in older women: a randomized double-blind studyStrength capacity in young patients who are receiving maintenance therapy for acute lymphoblastic leukemia: a case-control study.Effects of beta-alanine supplementation on brain homocarnosine/carnosine signal and cognitive function: an exploratory study.Exercise training, creatine supplementation, and bone health in ovariectomized rats.(In)Consistencies in Responses to Sodium Bicarbonate Supplementation: A Randomised, Repeated Measures, Counterbalanced and Double-Blind StudyNo effect of creatine supplementation on oxidative stress and cardiovascular parameters in spontaneously hypertensive rats.Beta-alanine (Carnosyn™) supplementation in elderly subjects (60-80 years): effects on muscle carnosine content and physical capacity.Proposal for a Candidate Core Set of Fitness and Strength Tests for Patients with Childhood or Adult Idiopathic Inflammatory MyopathiesDoes long-term creatine supplementation impair kidney function in resistance-trained individuals consuming a high-protein diet?Exercise training in childhood-onset systemic lupus erythematosus: a controlled randomized trial.Additive effects of beta-alanine and sodium bicarbonate on upper-body intermittent performanceExploring the therapeutic role of creatine supplementation.The liposuction-induced effects on adiponectin and selected cytokines are not affected by exercise training in women.Influence of training status on high-intensity intermittent performance in response to β-alanine supplementation.Evidence for prescribing exercise as treatment in pediatric rheumatic diseases.Role of beta-alanine supplementation on muscle carnosine and exercise performance.In sickness and in health: the widespread application of creatine supplementation.Exercise as a therapeutic tool to counteract inflammation and clinical symptoms in autoimmune rheumatic diseases.Carnosine: from exercise performance to health.Nitrate supplementation and human exercise performance: too much of a good thing?Acute exercise does not impair renal function in nondialysis chronic kidney disease patients regardless of disease stage.Creatine supplementation in the aging population: effects on skeletal muscle, bone and brain.Pneumatic Compression, But Not Exercise, Can Avoid Intradialytic Hypotension: A Randomized Trial.β-alanine supplementation to improve exercise capacity and performance: a systematic review and meta-analysis.Chronic lactate supplementation does not improve blood buffering capacity and repeated high-intensity exercise.Physical inactivity and sedentary behavior: Overlooked risk factors in autoimmune rheumatic diseases?Physical activity for paediatric rheumatic diseases: standing up against old paradigms.Efficacy and safety of concurrent training in systemic sclerosis.
P50
Q26830631-ED2920FF-6DA2-49D1-9132-04D3BEF2B49CQ27310016-6B920B38-E78F-4013-83D7-00D94FCF8451Q28269815-CB822AB1-78A0-4FC4-A1FB-5ECF254D1FF9Q30468275-5C1A3C4E-3D95-4FAC-82ED-E7FD2A51DFA1Q33672109-362C6955-7A8C-4968-8A8E-4E6AF4BC9BBCQ33755523-E16A82CF-66CF-4525-8B37-00FFC7D57EC7Q33830118-CC66B01F-5448-49B7-8F6C-8D93EEFAFB83Q33925777-4930B76B-C69E-40A3-A196-A55F6EDA88CAQ34374675-9B865627-32BE-42EA-AC2E-8D63A776ABB7Q34515226-3501CBB7-E277-4BA9-A2F7-EA545C3F0262Q34760752-EACA9C74-BB54-4B41-8C5A-9E1D604C67B5Q34980463-B2C62281-82A3-4B16-90B5-3DA02EAB82C2Q35009362-B3DA12A5-E6FE-4EF2-A2B5-CE86384F5FFFQ35142004-5CBA552F-C490-4C65-B2B8-5E25C51919D7Q35416763-55D5B3A6-4B6A-4E65-AC2C-880A09E4132BQ35542463-9448CCF7-2BE4-4049-97B2-5E3461C5964AQ35843413-5033D3A1-8F6B-4A48-8CFB-603A9030F625Q35930360-2DCD5C79-53A1-45A6-B2A5-AFFED150FD07Q36028657-F3ED80EB-DEF3-409C-83C1-1F08E3CA463FQ36421845-D3202E2D-FAB7-4801-B465-76A09CC3429FQ36866823-A1DDF9ED-09A5-4095-BDC1-7F468226FB7AQ36903145-A74E3E4A-2A2E-4096-926D-76F70D1504B8Q37022825-120AFFD1-9DC2-4BA2-8923-BA0B4C3C01E1Q37404612-6E62BA8C-C2F4-46BB-A5B3-1FF744100C61Q37541952-5D6F9640-4EE3-42F5-BAB3-B0AA03FD9C12Q37699136-B692AC7B-4CE2-4E74-96AE-B9245315387CQ37730276-CFAEBC83-70AE-46E2-8F45-AEA3AF34DCBFQ37755939-5AAD2B0E-13A7-4C37-B03E-F7E1277FF3AAQ37958749-643193BE-4871-4FFB-A3A8-D68BCED4EFE9Q38024936-6DE62F3E-61C1-4C47-9F78-347C95E3BE4CQ38088188-AE8EE86D-8EAD-4BAE-91E2-96E3A807D940Q38602185-06CF83D7-9EC5-478A-B949-60379FB6482CQ38780185-2FEEA12B-8B60-4A84-86AE-C091FCC3A6AEQ38815891-1AC64B25-C7AC-41EF-ACBA-A4A79281A4EEQ38837987-96431543-3632-4A70-BD69-B1206141B155Q38995065-4D016D0D-F1BC-47BC-AAE3-097CD29BEC8CQ39157129-3D88EA85-5968-46D6-90DD-28C27CBDB352Q39289329-E8B7957C-7FD2-4B91-91C7-D68F439250A1Q39323590-6026FC10-D790-4BD0-B035-2E89E7E3D467Q39960659-9C61E06A-24DA-4DFD-8D44-B964F6F2C110
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Bruno Gualano
@ast
Bruno Gualano
@en
Bruno Gualano
@es
Bruno Gualano
@nl
Bruno Gualano
@sl
type
label
Bruno Gualano
@ast
Bruno Gualano
@en
Bruno Gualano
@es
Bruno Gualano
@nl
Bruno Gualano
@sl
prefLabel
Bruno Gualano
@ast
Bruno Gualano
@en
Bruno Gualano
@es
Bruno Gualano
@nl
Bruno Gualano
@sl
P106
P21
P31
P496
0000-0001-7100-8681